Fallbericht
Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report.
Batna Journal of Medical Sciences (BJMS) · 01.06.2026 · 13 (6)
DOI: 10.48087/bjms.2026.130618 ↗Kurz gefasst
Fallbericht in der Zeitschrift Batna Journal of Medical Sciences (BJMS), online erschienen am 01.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report. Batna Journal of Medical Sciences (BJMS), 13(6). https://doi.org/10.48087/bjms.2026.130618
Vancouver
Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report. Batna Journal of Medical Sciences (BJMS). 2026;13(6). doi:10.48087/bjms.2026.130618
BibTeX
@article{euvimed2026,
title = {Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report},
journal = {Batna Journal of Medical Sciences (BJMS)},
year = {2026},
volume = {13},
number = {6},
doi = {10.48087/bjms.2026.130618}
}
EUVIMED